CME Group (NASDAQ:CME) Shares Bought by Macquarie Group Ltd.

Macquarie Group Ltd. grew its position in CME Group (NASDAQ:CME) by 816.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 745,939 shares of the financial services provider’s stock after purchasing an additional 664,523 shares during the quarter. Macquarie Group Ltd. owned approximately 0.22% of CME Group worth $121,811,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Raymond James Financial Services Advisors Inc. boosted its position in shares of CME Group by 7.6% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 369,133 shares of the financial services provider’s stock worth $50,090,000 after purchasing an additional 26,047 shares during the period. Candriam Luxembourg S.C.A. boosted its position in shares of CME Group by 4.9% in the third quarter. Candriam Luxembourg S.C.A. now owns 23,717 shares of the financial services provider’s stock worth $3,218,000 after purchasing an additional 1,107 shares during the period. Global X MANAGEMENT CO LLC boosted its position in shares of CME Group by 7.9% in the third quarter. Global X MANAGEMENT CO LLC now owns 7,626 shares of the financial services provider’s stock worth $1,035,000 after purchasing an additional 559 shares during the period. Los Angeles Capital Management & Equity Research Inc. lifted its holdings in shares of CME Group by 1,095.2% in the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 168,712 shares of the financial services provider’s stock worth $22,891,000 after buying an additional 154,596 shares in the last quarter. Finally, Teacher Retirement System of Texas lifted its holdings in shares of CME Group by 31.0% in the third quarter. Teacher Retirement System of Texas now owns 4,626 shares of the financial services provider’s stock worth $628,000 after buying an additional 1,095 shares in the last quarter. Institutional investors and hedge funds own 83.11% of the company’s stock.

CME Group stock traded down $4.73 during mid-day trading on Friday, reaching $158.26. 1,313,788 shares of the company’s stock traded hands, compared to its average volume of 2,112,036. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.10. CME Group has a 12-month low of $114.82 and a 12-month high of $171.71. The company has a market cap of $55,479.36, a price-to-earnings ratio of 33.18, a PEG ratio of 2.25 and a beta of 0.56.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. During the same quarter in the previous year, the business posted $1.14 earnings per share. The business’s revenue was down 1.4% compared to the same quarter last year. equities research analysts anticipate that CME Group will post 6.89 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 26th. Shareholders of record on Friday, March 9th were given a dividend of $0.70 per share. This is a boost from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date was Thursday, March 8th. This represents a $2.80 dividend on an annualized basis and a yield of 1.77%. CME Group’s payout ratio is 58.70%.

Several equities analysts have recently commented on the stock. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $180.00 target price on the stock in a report on Friday. Barclays boosted their target price on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a report on Friday, February 2nd. Sandler O’Neill reissued a “buy” rating and issued a $175.00 target price on shares of CME Group in a report on Friday, February 2nd. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a report on Tuesday, March 27th. Finally, Deutsche Bank upped their price target on shares of CME Group from $185.00 to $197.00 and gave the company a “buy” rating in a research note on Friday. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $163.69.

In other CME Group news, insider Derek Sammann sold 2,400 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $161.66, for a total transaction of $387,984.00. Following the transaction, the insider now owns 40,153 shares in the company, valued at $6,491,133.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 3,299 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $163.52, for a total transaction of $539,452.48. The disclosure for this sale can be found here. Insiders have sold 40,699 shares of company stock worth $6,266,062 in the last quarter. Company insiders own 0.57% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/04/08/cme-group-inc-cme-shares-bought-by-macquarie-group-ltd.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply